Collecting Blood and Tissue Samples From People With Blood Cancers
Collects and stores blood, tissue and fluid samples from adults evaluated for blood cancer.
Key facts
- Who runs it
- UNC Lineberger Comprehensive Cancer Center
- Where
- Chapel Hill, United StatesSee the site
- Trial code
- Registry title
- Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
- Status
- Recruiting
- People taking part
- 15,000 people, planned
- Started
- Jul 2009
- Expected to end
- Jul 2040
- Type of study
- Observational
- Treatments tested
- biologic sample preservation procedure
- cytology specimen collection procedure
- Record updated
- 28 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults being checked or treated for a blood or lymph cancer or related blood disease. Samples of blood and tissue are collected and stored for future research.
- Age
- 18 to 120 years
- Sex
- All sexes can join.
- Disease stage
- A diagnosis of a blood or lymph cell disease, such as acute myeloid leukemia, acute lymphoblastic leukemia, chronic myelogenous leukemia, chronic lymphoid leukemia, non-Hodgkin lymphoma, Hodgkin lymphoma, myelodysplastic syndromes, myeloproliferative disorders, multiple myeloma, Waldenstrom macroglobulinemia or aplastic anemia.
The registry criteria, word for word
Show all 5 criteriaShow less
Other criteria
- DISEASE CHARACTERISTICS:
- Diagnosis of abnormal hematopoietic/lymphoid cancer, including any of the following:; Acute myeloid leukemia; Acute lymphoblastic leukemia; Chronic myelogenous leukemia; Chronic lymphoid leukemia; Non-Hodgkin lymphoma; Hodgkin lymphoma; Myelodysplastic syndromes; Myeloproliferative disorders; Multiple myeloma; Waldenstrom macroglobulinemia; Aplastic anemia; Any other diseases that generate abnormalities in either number, function, or both of any cell type of hematolymphoid lineage
- Patients who are being evaluated at the hematology/oncology clinics of the University of North Carolina Hospitals, at the stem cell transplant clinic, or in the hospital; PATIENT CHARACTERISTICS:
- Not specified; PRIOR CONCURRENT THERAPY:
- Not specified
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 120 years old?
Where in United States
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel HillChapel Hill, United StatesContact: Tissue Procurement FacilityTaking people
About the trial
What the trial wants to find out
RATIONALE: Collecting and storing samples of tissue, blood, and body fluid from patients with cancer to study in the laboratory may help the study of cancer in the future.
Read full original descriptionShow less
PURPOSE: This research study is collecting and storing blood and tissue samples from patients being evaluated for hematologic cancer.
Treatments tested
- biologic sample preservation procedure
- cytology specimen collection procedure
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Tissue Procurement For Hematolymphoid Conditions
- Plain-language title
- Collecting Blood and Tissue Samples From People With Blood CancersGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT01137643, who can take part
- Record updated
- 28 October 2026